scispace - formally typeset
Open AccessJournal ArticleDOI

Generation of Functional Murine Cardiac Myocytes From Induced Pluripotent Stem Cells

Reads0
Chats0
TLDR
The aim of this study was to characterize the cardiac differentiation potential of a murine iPS cell clone in comparison to a well-established murine ES cell line, and found that iPS cells differentiate into functional cardiomyocytes.
Abstract
Background— The recent breakthrough in the generation of induced pluripotent stem (iPS) cells, which are almost indistinguishable from embryonic stem (ES) cells, facilitates the generation of murine disease– and human patient–specific stem cell lines. The aim of this study was to characterize the cardiac differentiation potential of a murine iPS cell clone in comparison to a well-established murine ES cell line. Methods and Results— With the use of a standard embryoid body–based differentiation protocol for ES cells, iPS cells as well as ES cells were differentiated for 24 days. Although the analyzed iPS cell clone showed a delayed and less efficient formation of beating embryoid bodies compared with the ES cell line, the differentiation resulted in an average of 55% of spontaneously contracting iPS cell embryoid bodies. Analyses on molecular, structural, and functional levels demonstrated that iPS cell–derived cardiomyocytes show typical features of ES cell–derived cardiomyocytes. Reverse transcription p...

read more

Citations
More filters
Journal ArticleDOI

Nano-Enabled Approaches for Stem Cell-Based Cardiac Tissue Engineering.

TL;DR: Tissue engineering strategies, which have emphasized on the use of nano‐enabled approaches in combination with stem cells for regeneration and repair of injured myocardium upon myocardial infarction (MI), are explored.
Journal ArticleDOI

MicroRNA-199b Modulates Vascular Cell Fate During iPS Cell Differentiation by Targeting the Notch Ligand Jagged1 and Enhancing VEGF Signaling.

TL;DR: A novel role for miR‐199b is indicated as a regulator of the phenotypic switch during vascular cell differentiation derived from iPS cells by regulating critical signaling angiogenic responses.
Journal ArticleDOI

The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications.

TL;DR: The basic concept of induction of pluripotency is reviewed as a novel approach to understand cardiac regeneration, cardiovascular disease modeling, and drug discovery and critically reflect on the current results of pre-clinical and clinical studies using iPSC.
Journal ArticleDOI

Generation of murine hepatic lineage cells from induced pluripotent stem cells.

TL;DR: In vivo assays revealed that the mouse iPS cell-derived hepatocytes successfully engrafted into the recipient livers with typical hepatic morphology and may hold great promise as a unique system for basic liver research and liver regeneration in the near future.
References
More filters
Journal ArticleDOI

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

TL;DR: Induction of pluripotent stem cells from mouse embryonic or adult fibroblasts by introducing four factors, Oct3/4, Sox2, c-Myc, and Klf4, under ES cell culture conditions is demonstrated and iPS cells, designated iPS, exhibit the morphology and growth properties of ES cells and express ES cell marker genes.
Journal ArticleDOI

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

TL;DR: It is demonstrated that iPS cells can be generated from adult human fibroblasts with the same four factors: Oct3/4, Sox2, Klf4, and c-Myc.
Journal ArticleDOI

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

TL;DR: This article showed that OCT4, SOX2, NANOG, and LIN28 factors are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells.
Journal ArticleDOI

Bone marrow cells regenerate infarcted myocardium

TL;DR: It is indicated that locally delivered bone marrow cells can generate de novo myocardium, ameliorating the outcome of coronary artery disease.
Journal ArticleDOI

Generation of germline-competent induced pluripotent stem cells

TL;DR: iPS cells competent for germline chimaeras can be obtained from fibroblasts, but retroviral introduction of c-Myc should be avoided for clinical application.
Related Papers (5)